pentobarbital will reduce the level or impact of fentanyl transdermal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with CYP3A4 inducers may lead to a lower in fentanyl plasma concentrations, deficiency of efficacy or, potentially, improvement of the withdrawal syndrome in a v